Search

Your search keyword '"Abdelazim AH"' showing total 57 results

Search Constraints

Start Over You searched for: Author "Abdelazim AH" Remove constraint Author: "Abdelazim AH"
57 results on '"Abdelazim AH"'

Search Results

1. Spectrofluorometric determination of ascorbic acid in the plasma matrix: Exploring correlation with autism spectrum disorder.

2. Spectrofluorometric determination of futibatinib in human plasma and pharmaceutical formulations.

3. Efficacy of forskolin as a promising therapy for chronic olfactory dysfunction post COVID-19.

4. Paper based analytical devices for ions determination in nasal secretions demonstrating association with olfactory function.

5. Spectrofluorometric determination of calcium in the human nasal secretions investigating the association with olfactory function.

6. Application of signal processing techniques for the spectroscopic analysis of dolutegravir and lamivudine: a comparative assessment and greenness appraisal.

7. Development of fluorescence probe for spectrofluorimetric determination of viloxazine hydrochloride in pharmaceutical form and rat plasma; additional pharmacokinetic study.

8. A fluorescence chemo sensor approach for determination of finerenone in pharmaceutical formulation and human plasma: Method development and validation.

9. Development of fluorescence chemo sensor for selective histamine determination in spiked human plasma samples.

10. Augmented least squares, a powerful chemometric approach for the spectroscopic analysis of the antiretroviral therapy abacavir, lamivudine and dolutegravir in their ternary mixture.

11. Reconstruction of Upper Third Defect of the Auricle by Conchal Cartilage Graft and Coverage by Postauricular Flap.

12. Efficient and eco-friendly detection of gabapentin using nitrogen-doped carbon quantum dots: an analytical and green chemistry approach.

13. Exploring the role of copper and zinc in chronic otitis media: A novel spectrofluorometric method for precise determination and association study.

14. Development of a spectrofluorometric method for selective and sensitive determination of zinc in human Plasma: Implications for olfactory function.

15. Novel spectrofluorometric method utilizing functionalized carbon quantum dots for determining histamine levels in nasal secretions: Implications for allergic rhinitis.

16. Innovative spectrofluorometric method for determination of harmaline and harmine in different matrices.

17. Intra Nasal Use of Ethylene Diamine Tetra Acetic Acid for Improving Olfactory Dysfunction Post COVID-19.

18. Synchronous spectrofluorimetric determination of favipiravir and aspirin at the nano-gram scale in spiked human plasma; greenness evaluation.

19. Higher sensitive selective spectrofluorometric determination of ritonavir in the presence of nirmatrelvir: application to new FDA approved co-packaged COVID-19 pharmaceutical dosage and spiked human plasma.

20. Adjusted green spectrophotometric determination of favipiravir and remdesivir in pharmaceutical form and spiked human plasma sample using different chemometric supported models.

21. Efficacy of pentasodium diethylenetriamine pentaacetate in ameliorating anosmia post COVID-19.

22. Green-adapted spectrophotometric determination of fostemsavir based on selective bromophenol blue extraction; reduction of hazardous consumption using computational calculations.

23. Quantitative analysis of two COVID-19 antiviral agents, favipiravir and remdesivir, in spiked human plasma using spectrophotometric methods; greenness evaluation.

24. Simultaneous green TLC determination of nirmatrelvir and ritonavir in the pharmaceutical dosage form and spiked human plasma.

25. Green fitted second derivative synchronous spectrofluorometric method for simultaneous determination of remdesivir and apixaban at Nano gram scale in the spiked human plasma.

26. Spectrophotometric Quantitative Analysis of Aspirin and Vonoprazan Fumarate in Recently Approved Fixed-Dose Combination Tablets Using Ratio Spectra Manipulating Tools.

27. Different spectrophotometric methods for simultaneous determination of lesinurad and allopurinol in the new FDA approved pharmaceutical preparation; additional greenness evaluation.

28. Green adherent spectrophotometric determination of molnupiravir based on computational calculations; application to a recently FDA-approved pharmaceutical dosage form.

29. Adjusted green HPLC determination of nirmatrelvir and ritonavir in the new FDA approved co-packaged pharmaceutical dosage using supported computational calculations.

30. Spectrofluorimetric quantitative analysis of favipiravir, remdesivir and hydroxychloroquine in spiked human plasma.

31. Effect of Sodium Gluconate on Decreasing Elevated Nasal Calcium and Improving Olfactory Function Post COVID-19 Infection.

32. Quantitative Spectrophotometric Analysis of Celecoxib and Tramadol in Their Multimodal Analgesia Combination Tablets.

33. Application of Different UV Spectrophotometric Methods for Quantitative Analysis of Acotiamide and Esomeprazole.

34. Spectrophotometric quantitative analysis of lesinurad using extractive acid dye reaction based on greener selective computational approach.

36. Effect of intra-nasal nitrilotriacetic acid trisodium salt in lowering elevated calcium cations and improving olfactory dysfunction in COVID-19 patients.

37. Application of green first derivative synchronous spectrofluorometric method for quantitative analysis of fexofenadine hydrochloride and pseudoephedrine hydrochloride in pharmaceutical preparation and spiked human plasma.

38. Application of different quantitative analytical techniques for estimation of aspirin and omeprazole in pharmaceutical preparation.

39. Spectrophotometric quantitative analysis of remdesivir using acid dye reagent selected by computational calculations.

40. The effect of intra-nasal tetra sodium pyrophosphate on decreasing elevated nasal calcium and improving olfactory function post COVID-19: a randomized controlled trial.

41. Simultaneous spectrophotometric determination of finasteride and tadalafil in recently FDA approved Entadfi™ capsules.

42. Quantitative Analysis of Two Pharmaceutical Combinations Containing Amlodipine with Either Bisoprolol or Candesartan Using Different UV Spectrophotometric Methods.

43. Application of different spectrophotometric methods for quantitative analysis of direct acting antiviral drugs simeprevir and sofosbuvir.

44. Comparative evaluation of different mathematical models for simultaneous UV spectrophotometric quantitative analysis of velpatasvir and sofosbuvir.

45. Application of different spectrofluorimetric approaches for quantitative determination of acetylsalicylic acid and omeprazole in recently approved pharmaceutical preparation and human plasma.

46. Simultaneous spectrophotometric quantitative analysis of elbasvir and grazoprevir using assisted chemometric models.

47. Application of different chemometric assisted models for spectrophotometric quantitative analysis of velpatasvir and sofosbuvir.

48. Simultaneous spectrophotometric quantitative analysis of velpatasvir and sofosbuvir in recently approved FDA pharmaceutical preparation using artificial neural networks and genetic algorithm artificial neural networks.

49. Different chemometric assisted approaches for spectrophotometric quantitative analysis of lesinurad and allopurinol.

50. Simultaneous determination of elbasvir and grazoprevir in their pharmaceutical formulation by synchronous fluorescence spectroscopy coupled to dual wavelength method.

Catalog

Books, media, physical & digital resources